from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3025c/iscS

LFCtreatmentdescriptionclass of inhibitor

-0.054

Amikacinug/mL Amikacintranslation

-0.481

Cap5-10ug/mL Capreomycintranslation

0.296

Rox10-50 ug/mL Roxithromycintranslation

0.375

SM2-5 ug/mL Streptomycintranslation

0.295

Tet5-10 ug/mL Tetracyclinetranslation

1.846

Rif0.2-5ug/mL Rifampicintranscription

0.465

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.735

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.425

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.055

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.159

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.013

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.563

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.121

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.081

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.147

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.686

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.693

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.106

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.426

KCN5-20 ug/mL Potassium cyaniderespiration

-0.444

NaN30.2-2 mM Sodium aziderespiration

-0.253

Nigericin50 uM Nigericinrespiration

-1.095

TRC10-150 ug/mL Triclosanrespiration

-1.711

TRZ10-25 ug/mL Thioridazinerespiration

-0.688

Valinomycin0.5-10 uM Valinomycinrespiration

-0.769

ZnSO42 mM ZnSO4respiration

-0.006

menadione6-10 ug/mL Menadionerespiration

-0.153

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.094

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.199

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.262

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.712

NRP_1Non-replicating persistence stage 1dosRassociated

0.738

Amp0.2mg/mL AmpicillincellWall

-0.141

Cephalexin20-100 ug/mL CephalexincellWall

-0.239

Cerulenin0.32-5 ug/mL CerulenincellWall

1.728

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.961

EMB10-20 ug/mL EthambutolcellWall

0.154

Eta12-40 ug/mL EthionamidecellWall

0.629

INH0.2-0.4 ug/mL IsoniazidcellWall

0.633

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.147

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.344

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.321

BZA0.12 mg/mL BenzamidearomaticAmides

-0.077

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.223

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.909

H2O24 mM hydrogen peroxideDNAdamaging

-0.313

Levo10 ug/mL LevofloxacinDNAdamaging

0.650

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-3.327

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.986

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.847

UVUV-irradiationDNAdamaging

0.171

ARP41-4 ug/mL Antitubercular compound ARP4?

0.338

Antimycin12.5-50 ug/mL Antimycin A?

-0.374

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.626

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.296

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.912

PA8240.2-2 ug/mL PA-824?

-0.663

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.124

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.380

Verapamil50 uM Verapamil?

-0.278

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.107

methoxatin10-20 ug/mL Methoxatin?